Arla targets €3.6bn clinical drink market with whey offering
date:Sep 04, 2012
The market, worth 4bn in the US and Europe, serves the elderly with health issues like muscle wasting or those who are recovering from illness or surgery; but it is a market that that has been a challenge for whey suppliers due to the manufacturing processes for ultra-high temperature (UHT) drinks.

Arla says its powdered, hydrolysed whey have overcome the issue, and nutritionally, can clear the gastric chamber faster than other protein forms and facilitate more efficient muscle synthesis. It is
1/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/06 10:51